Form4insider filings, from the source

SEC Form 3 · accession 0001179110-17-007360

Allergan plc · AGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Marc Princen
Officer — EVP and President Int'l Comml
Period of report
May 4, 2017
Accepted (ET)
May 16, 2017 · 9:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary Shares, par value $0.0001F1holding———8,298D
Ordinary Shares, par value $0.0001F2holding———3,492D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$192.81holding————Dec 16, 2021Ordinary Shares9,650—D
Performance-Based Restricted Share UnitF4—holding—————Ordinary Shares5,186—D
Performance-Based Restricted Share UnitF5—holding—————Ordinary Shares10,476—D

Explanation of responses